1. WWP2 binds to NKRF, enhances the NF-κB signaling, and promotes malignant phenotypes of acute myeloid leukemia cells
   Hongjia Wang et al, 2024, Biochemistry and Cell Biology CrossRef
2. Long-term effect of anesthesia choice on patients with hepatocellular carcinoma undergoing open liver resection
   Runzhi Zhao et al, 2023, Frontiers in Oncology CrossRef
3. Production of antifungal compounds from Bacillus paramycoides LBKURCC218 and Aspergillus fumigatus LBKURCC269 co-cultivation
   Zona Octarya et al, 2023, Materials Today: Proceedings CrossRef
4. WWP2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 protein
   Jianping Zou et al, 2023, Cell Communication and Signaling CrossRef
5. E3 ubiquitin ligase WWP2 as a promising therapeutic target for diverse human diseases
   Shilong You et al, 2024, Molecular Aspects of Medicine CrossRef
6. Molecular authentication, metabolite profiling and in silico–in vitro cytotoxicity screening of endophytic Penicillium ramusculum from Withania somnifera for breast cancer therapeutics
   Sherin Varghese et al, 2024, 3 Biotech CrossRef
7. Network-based drug repurposing for HPV-associated cervical cancer
   Faheem Ahmed et al, 2023, Computational and Structural Biotechnology Journal CrossRef
8. The role of E3 ubiquitin ligase WWP2 and the regulation of PARP1 by ubiquitinated degradation in acute lymphoblastic leukemia
   Xinxin Lu et al, 2022, Cell Death Discovery CrossRef
9. Apigenin promotes cell death in NCI-H23 cells by upregulation of PTEN: potential involvement of the binding of apigenin with WWP2 protein
   Sapna Mayuri Borah et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
10. The role of WWP1 and WWP2 in bone/cartilage development and diseases
    Ying Wang et al, 2024, Molecular and Cellular Biochemistry CrossRef
11. NEDD4 E3 ubiquitin ligases: Promising biomarkers and therapeutic targets for cancer
    Xianyan Tian et al, 2023, Biochemical Pharmacology CrossRef
12. Etomidate elicits anti-tumor capacity by disrupting the JAK2/STAT3 signaling pathway in hepatocellular carcinoma
    Jiali Xu et al, 2023, Cancer Letters CrossRef